409 Crystallization of Pharmaceutical and Biological Molecules II

Tuesday, November 17, 2020: 8:00 AM - 9:00 AM
Separations Division (02) (PreRecorded+)

Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Crystallization and Evaporation
Co-Sponsor(s):
Pharmaceutical Discovery, Development and Manufacturing Forum (26), Food, Pharmaceutical & Bioengineering Division (15)
Chair:
Chiajen Lai Email: chiajen.lai@gilead.com
Co-Chair:
Christopher L. Burcham Email: cburcham@lilly.com


(409a) Crystal Morphology Modification in a Nucleation Dominant Crystallization: A Tool from Traditional Chemistry
Tharanga Wijethunga, Michael Waldo and Sonja Sharpe


(409b) Process Development to Avoid Meta-Stable Liquid-Liquid Phase Separation during Crystallization of API
Patricia Cho, John Ryan Coombs, Victoria Mbachu and Eric M. Saurer


(409c) Decoupling Nucleation and Growth for Continuous Crystallization in Microfluidics
Naghmeh Fatemi, Tom Van Gerven and Simon Kuhn


(409d) Effects of Volume Reduction on Glycine Nucleation
Isaac Jerome C. Dela Cruz, Gerard Capellades, Jem Valerie D. Perez, Bryan G. Alamani and Allan S. Myerson


(409e) Formation of Solid Solutions As a Key Impurity Retention Mechanism in Solution Crystallization in the Presence of Structurally Similar Impurities
Fredrik Nordstrom


(409g) Design of a Continuous Crystallization for a Drug Substance Using a Dynamically Mixed Reactor
Srividya Ramakrishnan, Ramana Susarla, Suhas Jawlekar, Ravi Kumar Gorle, Jagannadharao Velaga, Manohar Venkatachalam and Yakoob Sardar Mohammed
See more of this Group/Topical: Separations Division
<< Previous Session | Next Session >>